Vai al contenuto principale della pagina
Titolo: | Marine Compounds and Cancer / / edited by Friedemann Honecker, Sergey A. Dyshlovoy |
Pubblicazione: | Basel : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2018 |
Descrizione fisica: | 1 online resource (v, 110 pages) |
Disciplina: | 615.945 |
Soggetto topico: | Cancer - Radiotherapy |
Marine toxins | |
Persona (resp. second.): | HoneckerFriedemann |
DyshlovoySergey A. | |
Sommario/riassunto: | The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development. |
Titolo autorizzato: | Marine Compounds and Cancer |
Formato: | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione: | Inglese |
Record Nr.: | 9910597915403321 |
Lo trovi qui: | Univ. Federico II |
Opac: | Controlla la disponibilità qui |